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Introduction
Bones and joints, i.e. the focus of the ﬁeld of orthopedics,
are basically aseptic tissues. The distribution of adminis-
tered antimicrobial agents in these tissues is lower than in
other organs, often making it impossible to cure infections
of bones and joints with antibiotics alone. In most cases
with bone and/or joint infections, antimicrobial agents must
be combined with surgical therapy. Gas gangrene and
fasciitis are also anaerobic infections seen in the ﬁeld of
orthopedics, but these two conditions are discussed in




Anaerobic infections affecting the bone frequently develop
after open fractures, infection secondary to anaerobic
infection of other organs, and foot osteomyelitis associated
with angiopathy or diabetes mellitus. Because the unique
structure of bone tissue makes it difﬁcult for inﬂammatory
cells to gather in the infected area and bacteria are likely to
form a bioﬁlm in the infected area, osteomyelitis tends to
assume the form of a chronic rather than an acute disease.
Causative bacteria
Staphylococcus aureus and Staphylococcus epidermidis are
generally responsible for osteomyelitis. Because of the
recent increase in the number of patients using adreno-
cortical steroids or immunosuppressant drugs and in the
number of diabetic patients, the prevalence of anaerobic
infection has been rising. Anaerobes often isolated from
patients with osteomyelitis are anaerobic gram-positive
cocci (Peptostreptococcus spp., Finegoldia magna, Parvi-
monas micra, etc.), Bacteroides spp. and Clostridium spp.
Among others, B. fragilis is isolated particularly fre-
quently. Osteomyelitis frequently assumes the form of a
mixed infection of anaerobes plus aerobes rather than
infection with anaerobes alone.
Diagnosis
Malodorous pus or the presence of a deep abscess or
necrotic tissue is a possible sign of anaerobic infection,
indicating the necessity of anaerobic culture. Gas pooling
revealed by X-ray is an important ﬁnding, but it is
important to notice that gas pooling is sometimes absent in
anaerobic infection cases and can even be seen even in
cases with aerobic infections.
Antimicrobial therapy
In cases strongly suspected of having an anaerobic infec-
tion, it is advisable to perform drip infusion of tazobactam/
piperacillin (TAZ/PIPC), sulbactam/ampicillin (SBT/ABPC)
or carbapenems (imipenem/cilastatin (IPM/CS), panipe-
nem/betamipron (PAPM/BP), etc.). In cases in which the
pathogen has been identiﬁed by culture, benzylpenicillin
(PCG), piperacillin (PIPC), etc. should be selected for
infections caused by anaerobic gram-positive cocci
belonging to Peptostreptococcus spp., Finegoldia spp.,
Micromonas spp., etc. Most bacteria of Bacteroides spp.
produce b-lactamase. Clindamycin (CLDM) is often used
for such cases. Other than this drug, cephamycins
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(cefmetazole (CMZ), etc.) and carbapenems (imipenem/
cilastatin, etc.) are also expected to be effective. Amino-
glycosides are ineffective against anaerobes [1].
Antibacterial agents are usually administered intrave-
nously. In osteomyelitis cases, the distribution of admin-
istered antimicrobial agents in the infected focus is often
low because necrotic bone or necrotic surrounding tissue
hampers this distribution. Usually, the distribution of
agents in bone marrow is about 1/10 of that in blood [2]. It
is therefore desirable that administration of the drug at a
dose allowing its blood concentration to reach a level
equivalent to 10 times the MIC (minimal inhibitory con-
centration) of the agent against the pathogen. To achieve
satisfactory efﬁcacy, therapy with antimicrobial agents
often need to be continued for 4–6 weeks, but there is no
uniform criterion for the duration of treatment. Responses
to antimicrobial chemotherapy are assessed on the basis of
changes in clinical symptoms, white blood cell (WBC),
C-reactive protein (CRP), erythrocyte sedimentation rate
(ESR), etc. In chronically infected cases, intravenous
antimicrobial chemotherapy is sometimes switched to oral
treatment with antimicrobial agents effective against
anaerobes [3]. Because suppurative osteomyelitis is likely
to relapse and long-term careful follow-up is essential, the
timing of antimicrobial agent discontinuation should be
determined paying close attention to the indicators listed
above.
Surgical treatment
The presence of sequestrum or necrotic tissue can lead to
expansion of the lesion and prolonged treatment. Adequate
curettage of the affected area is therefore essential. If
adequately treated, the duration of antimicrobial chemo-
therapy can be shortened. The most important surgical
manipulations are thorough debridement (including
removal of sequestrum, necrotic tissue, etc.), jet lavage
with massive amounts of physiological saline, and drain-
age. Inadequate surgical manipulations can prolong the
treatment period.
Closed continuous lavage
An infusion tube and a discharge tube are inserted into
the bone marrow. A cleanser, containing antimicrobial
agents, is then infused through the infusion tube to guide
necrotic tissue and bacteria out of the body via the dis-
charge tube. Kawashima et al. devised a circuit for pre-
vention of obstruction, employing a double-lumen serum
tube and this circuit has been widely used [4]. Lavage is
usually started with an initial volume of 5,000 mL and is
continued with a maintenance volume of 3,000 mL per
day.
Filling with cement beads containing antimicrobial agents
(spacer) [5]
This method uses bone cement (polymethylmethacrylate)
containing antimicrobial agents to which the pathogen is
susceptible. The aims are to ﬁll dead spaces and maintain
supra-effective local concentration of antimicrobial agent,
with the ultimate goal of eradicating the bacteria. With this
method, the local concentration of antimicrobial agent can
be kept above that needed to be effective for about 2 weeks
[6]. In cases of infection after hip replacement surgery, a
spacer is often used after prosthesis removal. It is also used
for prevention of bone shortening before planned recon-
struction and for preservation of the patient’s activity.
Oxygen under high pressure (OHP) therapy
With highperbaric oxygen therapy, arterial oxygen tension
is elevated, and the resulting rise in dissolved oxygen in
blood provides high concentrations of oxygen to tissues.
This therapy suppresses Clostridium spp. proliferation and
alleviates local ischemic condition. Although some inves-
tigators have described this therapy as being ineffective
against non-Clostridium spp. infection [7], it is known to
stimulate tissue repair and enhance neutrophil function. It
is also reportedly effective against aerobes. OHP therapy




Arthritis caused by anaerobes is either an outcome of
blood-borne transmission of bacteria from other tissues into
joints or of direct bacterial invasion of the joints due to
trauma, surgery, injection, etc. If articular cartilage is
destroyed by inﬂammation or the like associated with
infection, articular function is likely to be disturbed.
Causative bacteria
Anaerobic arthritis accounts for about 1% of all cases
of bacterial arthritis. It is most frequently attributable to
B. fragilis. Clostridium spp. is rarely responsible for this
infection [8].
Diagnosis
Clinical symptoms of this infection are fever, local swell-
ing, erythema and a sensation of heat. The range of motion
(ROM) is restricted by pain. Care is needed because
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patients with this infection sometimes show no typical
local signs, complaining only of pain, and gradually
develop articular destruction. If patients with a history of
systemic or intra-articular administration of adrenocortical
steroids show persistent pain or articular edema, the pos-
sibility of infectious arthritis (including anaerobic infec-
tion) should be kept in mind. A deﬁnitive diagnosis of this
infection is possible if culture of the synovial ﬂuid reveals
anaerobes. However, some cases with this infection have
negative anaerobic culture results. As in osteomyelitis
cases, it is not uncommon for patients with anaerobic
infection to show no signs of gas pooling in joints or
subcutaneous tissues when examined by diagnostic imag-
ing. Usually, there are no radiographic signs in the early
stages of infectious arthritis. However, if infection persists,
bone atrophy and articular destruction manifest in the
surrounding area [9].
Selection of antimicrobial agents and how to use them
Like osteomyelitis, anaerobic arthritis is treated by drip
infusion of TAZ/PIPC, SBT/ABPC, carbapenems (IPM/
CS, PAPM/BP, etc.) or CLDM. Treatment is continued for
about 2–4 weeks, with monitoring of changes in local
signs, WBC, CRP, ESR, etc. Oral agents effective against
anaerobes are administered, as needed, for about 2 months.
The most important aspect of treating infectious arthritis
is preserving the articular cartilage. It is essential to min-
imize the degree of pain and articular dysfunction
(including restricted ROM). Because lysis of cartilaginous
proteoglycan begins 24 h after bacterial invasion of joints,
the administration of treatment therapy must be start
urgently. It is clinically advisable for antimicrobial agents
to be administered immediately, followed by continuous
lavage, if suppurative arthritis is suspected. Cleansing with
an injector does not consistently allow adequate drainage
or cleansing and involves a risk of secondary infection. It is
desirable that synovectomy be performed under arthro-
scopic guidance, and that this be followed by adequate
cleansing and closed continuous lavage. It is difﬁcult to
manage suppurative arthritis with conservative therapy.
Rapid and appropriate treatment by specialists is essential.
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